CLINICAL_TRIALS trial_result · 2024-12-13

Clinical Trial Update: AMG 404 in Patients With Advanced Solid Tumors [Phase 1]

Amgen reports Phase 1 results for AMG 404 in patients with advanced solid tumors; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Amgen | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2024-12-13